SYSCHEM Stock View

Syschem (India) Ltd
stock-view-header

icon -1.50 | -2.57
Market Cap ₹( Cr.)
2,328.00
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
25-Feb-2024
 

The average score for Syschem (India) Ltd stands at 4 against 5, three months back.

Syschem (India) Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredient (API) / Intermediates. The Company operates through pharmaceuticals segment. The Company’s API/ Intermediates products include Amoxycillin Trihydrate; Ampicillin Trihydrate; Cloxacillin Sodium; Dicloxacillin Sodium; Flucloxacillin Sodium for export only; Cephalexin; Cefixime; Cefadroxil; Distillation of Specialty Solvents, such as dimethylformamide (DMF), acetonitrile, ethyl acetate and tetrahydrofuran (THF). It also engaged in the manufacturing of bulk drugs/ intermediates / specialty chemicals and contract manufacturing. The Company has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt. Panchkula Haryana.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
59.66
100 DMA(₹)
55.41
200 DMA(₹)
49.14
52 Weeks Range
33.36     73.90

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required